Tokuyama

Investors

Financial Results
for FY2024
Date: Apr 28, 2025

To Investors

Latest IR Reports
Financial Results for Q3 FY2024

Investor News

Apr 22, 2025: Notice Concerning the Acquisition of a Newly Established Company that will succeed JSR's in vitro diagnostic pharmaceutical business

Apr 22, 2025: Notice Concerning the Acquisition of a Newly Established Company that will succeed JSR’s in vitro diagnostic pharmaceutical business (Presentation)

Apr 22, 2025: Notice concerning Changes of Representative Directors and other Directors

Jan 31, 2025: Tokuyama Corporation Releases Q3 FY2024 Results

Jan 31, 2025: Notice concerning Revision of Performance Forecast for Fiscal 2024